نتائج البحث - "Cisar, Laura"

1

دورية أكاديمية

Hypertension among patients with renal cell carcinoma receiving axitinib or sorafenib: analysis from the randomized phase III AXIS trial

المؤلفون: Rini, Brian I., Quinn, David I., Baum, Michael, Wood, Laura S., Tarazi, Jamal, Rosbrook, Brad, Arruda, Lillian Shahied, Cisar, Laura, Roberts, W. Gregory, Kim, Sinil, Motzer, Robert J.

المصدر: Targeted Oncology ; volume 10, issue 1, page 45-53 ; ISSN 1776-2596 1776-260X

مصطلحات موضوعية: Pharmacology (medical), Cancer Research, Oncology

الإتاحة: https://doi.org/10.1007/s11523-014-0307-zTest

View record in BASE

2

دورية أكاديمية

Integrated Analysis of Molecular and Clinical Prognostic Factors in Stage II/III Colon Cancer

المؤلفون: Roth, Arnaud D., Delorenzi, Mauro, Tejpar, Sabine, Yan, Pu, Klingbiel, Dirk, Fiocca, Roberto, dArio, Giovanni, Cisar, Laura, Labianca, Roberto, Cunningham, David, Nordlinger, Bernard, Bosman, Fred, Van Cutsem, Eric

مصطلحات موضوعية: Article

وصف الملف: text/html

العلاقة: http://jnci.oxfordjournals.org/cgi/content/short/djs427v1Test; http://dx.doi.org/10.1093/jnci/djs427Test

الإتاحة: https://doi.org/10.1093/jnci/djs427Test
http://jnci.oxfordjournals.org/cgi/content/short/djs427v1Test

View record in BASE

3

دورية أكاديمية

Utility of Pretreatment Bilirubin Level and UGT1A1 Polymorphisms in Multivariate Predictive Models of Neutropenia Associated with Irinotecan Treatment in Previously Untreated Patients with Colorectal Cancer

المؤلفون: Parodi, Luis, Pickering, Eve, Cisar, Laura A., Lee, Doug, Soufi‐Mahjoubi, Raoudha

المصدر: Archives of Drug Information ; volume 1, issue 3, page 97-106 ; ISSN 1753-5174 1753-5174

الإتاحة: https://doi.org/10.1111/j.1753-5174.2008.00014.xTest

View record in BASE

4

دورية أكاديمية

Plasma tissue factor antigen levels in capillary whole blood and venous blood: Effect of tissue factor on prothrombin time

المؤلفون: Quien, Emmanuel T., Morales, Enid, Cisar, Laura A., Kim, Hugh C., Cimini, Catherine, Saidi, Parvin, Philipp, Claire S.

المصدر: American Journal of Hematology ; volume 55, issue 4, page 193-198 ; ISSN 0361-8609 1096-8652

الإتاحة: https://doi.org/10.1002Test/(sici)1096-8652(199707)55:4%3C193::aid-ajh5%3E3.0.co%3B2-n

View record in BASE

5

دورية أكاديمية

Hereditary protein S deficiency in a large New Jersey kindred

المؤلفون: Wilkerson, Donald K., Burrell, Lillian, Cisar, Laura A., Graham, Alan M., Kim, Hugh

المصدر: Journal of Vascular Surgery ; volume 18, issue 6, page 932-938 ; ISSN 0741-5214

مصطلحات موضوعية: Cardiology and Cardiovascular Medicine, Surgery

الإتاحة: https://doi.org/10.1016/0741-5214Test(93)90547-y
https://api.elsevier.com/content/article/PII:074152149390547Y?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:074152149390547Y?httpAccept=text/plainTest

View record in BASE

6

دورية أكاديمية

Axitinib in metastatic renal cell carcinoma: patient characteristics and treatment patterns in US community oncology centers

المؤلفون: Hutson, Thomas E, Jiao, Xiaolong, Wilson, Thomas, Cisar, Laura, MacLean, Elizabeth A

المساهمون: J Vas of Engage Scientific Solutions

المصدر: Future Oncology ; volume 13, issue 15, page 1323-1332 ; ISSN 1479-6694 1744-8301

الإتاحة: https://doi.org/10.2217/fon-2016-0566Test

View record in BASE

7

دورية أكاديمية

Long-term Duration of First-Line Axitinib Treatment in Advanced Renal Cell Carcinoma

المؤلفون: Rini, Brian I., Gruenwald, Victor, Jonasch, Eric, Fishman, Mayer N., Tomita, Yoshihiko, Michaelson, M. Dror, Tarazi, Jamal, Cisar, Laura, Hariharan, Subramanian, Bair, Angel H., Rosbrook, Brad, Hutson, Thomas E.

المساهمون: Pfizer

المصدر: Targeted Oncology ; volume 12, issue 3, page 333-340 ; ISSN 1776-2596 1776-260X

مصطلحات موضوعية: Pharmacology (medical), Cancer Research, Oncology

الإتاحة: https://doi.org/10.1007/s11523-017-0487-4Test

View record in BASE

8

دورية أكاديمية

Real-world chart review study of adverse events management in patients taking tyrosine kinase inhibitors to treat metastatic renal cell carcinoma

المؤلفون: Srinivas, Sandy, Stein, Dara, Teltsch, Dana Y, Tao, Sunning, Cisar, Laura, Ramaswamy, Krishnan

المصدر: Journal of Oncology Pharmacy Practice ; volume 24, issue 8, page 574-583 ; ISSN 1078-1552 1477-092X

مصطلحات موضوعية: Pharmacology (medical), Oncology

الإتاحة: https://doi.org/10.1177/1078155217719583Test

View record in BASE

9

دورية أكاديمية

Real-world chart review study of adverse events management in patients taking tyrosine kinase inhibitors to treat metastatic renal cell carcinoma.

المؤلفون: Srinivas, Sandy, Stein, Dara, Tao, Sunning, Teltsch, Dana Y., Cisar, Laura, Ramaswamy, Krishnan

المصدر: Journal of Oncology Pharmacy Practice; Dec2018, Vol. 24 Issue 8, p574-583, 10p, 1 Diagram, 3 Charts, 3 Graphs

مصطلحات موضوعية: ADVERSE health care events, DIARRHEA, FATIGUE (Physiology), HYPERTENSION, MEDICAL history taking, METASTASIS, RENAL cell carcinoma, STOMATITIS, PROTEIN-tyrosine kinase inhibitors, TERMINATION of treatment, RETROSPECTIVE studies, HAND-foot syndrome, MUCOSITIS, SORAFENIB, THERAPEUTICS, PREVENTION

10

دورية أكاديمية

Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor study

المؤلفون: Grill, Jacques, Geoerger, Birgit, Gesner, Lyle, Perek, Danuta, Leblond, Pierre, Cañete Nieto, Adela, Aerts, Isabelle, Madero, Luis, de Toledo Codina, Josep Sanchez, Verlooy, Joris, Estlin, Edward, Cisar, Laura, Breazna, Aurora, Dorman, Andrew, Bailey, Simon, Nicolin, Gary, Grundy, Richard G., Hargrave, Darren

مصطلحات موضوعية: medulloblastoma, temozolomide, TEMIRI

العلاقة: http://hdl.handle.net/10550/44467Test; 090233

الإتاحة: https://doi.org/10.1093/neuonc/not097Test
http://hdl.handle.net/10550/44467Test

View record in BASE

تنقيح النتائج